EXHIBIT A: Joint Filing Agreement

In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the ordinary shares, par value $0.001 per share, of Tongjitang Chinese Medicines Company, a Cayman Islands company, and that this Agreement may be included as an Exhibit to such joint filing. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

[Remainder of this page has been left intentionally blank.]


Signature Page

IN WITNESS WHEREOF, the undersigned hereby execute this Agreement as of February 14, 2008.

 

Merrill Lynch & Co., Inc.   By:  

/s/ Frank J. Marinaro

  Name:   Frank J. Marinaro
  Title:   Assistant Secretary
ML Global Private Equity Fund, L.P.   Acting by MLGPE Ltd., the general partner of ML Global Private Equity Fund, L.P.
  By:  

/s/ Frank J. Marinaro

  Name:   Frank J. Marinaro
  Title:   Vice President and Secretary